Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.Eli Lilly is suing four telehealth companies selling compounded versions of the pharmaceutical giant's weight loss drug Zepbound and its diabetes treatment Mounjaro, the company's latest attempt to crack down on the booming industry of copycat drugs.In lawsuits filed Wednesday, Lilly accuses the sites — Mochi Health, Fella Health, Willow Health and Henry Meds — of deceiving consumers about "untested, u ...